HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway.

AbstractAIMS AND METHODS:
Acute myocardial infarction (AMI) is a common cardiovascular disease with high mortality. Astragaloside IV (AS-IV) was reported to have cardioprotective effect after AMI. We hypothesize that the cardioprotective role of AS-IV is exerted by enhancing angiogenesis via regulating PTEN/PI3K/Akt signaling pathway. To valid our hypothesis, AMI rats and human umbilical vein endothelial cells (HUVECs) were employed in our study.
KEY FINDINGS:
After treatment, cardiac function, survival rate, infarct size, pathological changes and fibrosis, cell apoptosis, ultrastructural changes, angiogenesis and expression of PTEN/PI3K/Akt signaling pathway were evaluated, respectively. In vitro study we detected proliferation, tube formation and signaling pathway activation of HUVECs treated with AS-IV, lentivirus overexpressed PTEN was employed to elucidate the potential mechanism. The results indicated that AS-IV administration significantly improved cardiac function and survival rate, limited infarct size, ameliorated pathological changes and fibrosis deposition, inhibited apoptosis, relieved ultrastructure injury and enhanced angiogenesis, PTEN/PI3K/Akt signaling pathway was activated simultaneously compared to the model group. In vitro study suggested that AS-IV treatment promoted cell proliferation and tube formation, and induced PTEN/PI3K/Akt signaling pathway activation. Importantly, overexpression of PTEN by lentivirus abolished AS-IV-induced angiogenesis.
SIGNIFICANCE:
Our study indicated that AS-IV could promote angiogenesis and cardioprotection after myocardial infarction. The mechanisms involve activation of PTEN/PI3K/Akt signaling pathway.
AuthorsSongyi Cheng, Xiaoxiao Zhang, Qian Feng, Jiandong Chen, Le Shen, Peng Yu, Li Yang, Daohai Chen, Haowen Zhang, Weixin Sun, Xiaohu Chen
JournalLife sciences (Life Sci) Vol. 227 Pg. 82-93 (Jun 15 2019) ISSN: 1879-0631 [Electronic] Netherlands
PMID31004658 (Publication Type: Journal Article)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Chemical References
  • Angiogenesis Inducing Agents
  • Cardiotonic Agents
  • Saponins
  • Triterpenes
  • Vascular Endothelial Growth Factor A
  • astragaloside A
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • PTEN Phosphohydrolase
Topics
  • Angiogenesis Inducing Agents
  • Animals
  • Apoptosis (drug effects)
  • Cardiotonic Agents
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Male
  • Myocardial Infarction (drug therapy, metabolism)
  • Neovascularization, Pathologic (metabolism)
  • PTEN Phosphohydrolase (drug effects, metabolism)
  • Phosphatidylinositol 3-Kinases (drug effects, metabolism)
  • Proto-Oncogene Proteins c-akt (drug effects, metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Saponins (metabolism, pharmacology)
  • Signal Transduction (drug effects)
  • Triterpenes (metabolism, pharmacology)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: